There are several rapid microbiological methods becoming available that have useful applications in pharmaceutical and medical devices. They are ATP bioluminescence, fluorescent labeling, electrical resistance, and nucleic acid probes. In choosing to employ rapid methods, the microbiologist should examine their prospective performances against the specific requirements for that sector. Some methods may require expensive equipment and offer full automation, and others represent only a small investment. The regulatory view of these methods is changing and they still officially have not been approved in medical and pharmaceutical area, but it will still be up to the microbiologist to demonstrate that the method chosen is fit for the purpose intended.
INTRODUCTION
Traditional microbiological methods of detection, enumeration, and identification using mostly culture methods are so often time-consuming and labor-intensive. These practical considerations often limit the extent to which microbiological tests are routinely applied both at the formulation development stage i.e., preservative screening and for microbiological quality assurance MQA . In the latter instance, the inevitable time delay associated with incubation often determines that MQA data are only of retrospective value. Pharmaceutical and medical device production can no longer accommodate this delay Zuluaga et al., 2009; Akselband et al., 2005; Dexter et al., 2003 . Considerable benefit would therefore be gained from the introduction of suitable, more rapid methods of microbiological analysis to the pharmaceutical and medical device sector. For these purposes, this review article has been prepared. The typical requirements for such rapid methods are summarized in Table 1 .
CURRENTLY AVAILABLE RAPID METHODS AND THEIR BRIEF EXPLANATION
The development of rapid methods has been largely fed by the food, dairy, water, and medical diagnostics industries and has resulted in a diverse range of methods Table 2 . However, they are not always suited to pharmaceutical and medical devices due to the large difference in the number of contaminating microorganisms. Their procedures of detection may be direct, in which individual microorganisms or populations of organisms are directly observed, or indirect, whereby microbial metabolism, metabolites, or components can be Pettipher, 1983; Hutcheson et al., 1988; Rodrigues and Kroll, 1988; Rodrigues and Kroll, 1990; Diaper and Edwards, 1994; Nebe-von Caron et al., 1998; Newby, 2000; Van Poucke and Nelis, 2000; DeCory et al., 2005 , electrical resistance Baynes et al., 1983 Owens and WacherViveros, 1986; Silley and Forsythe, 1996; Newby, 2000 , enzyme monitoring Kroll and Rodrigues, 1986; Watling and Leech, 1996; Newby, 2000 , Limulus amoebocyte lysate Jorgensen and Alexander, 1981; Bussey and Tsuji, 1984; Baines, 2000 , nucleic acid probes Bauters et al., 1999 Jordan, 2000; Newby, 2000; Dunsmoor et al., 2001; Jimenez et al., 2001; Serin et al., 2005; Chaieb et al., 2007; Zuluaga et al., 2009 , phage-interaction technology Wolber and Green, 1990; Turpin et al., 1993; Stewart et al., 1996; Stewart et al., 1998; Mole et al., 1999; Wu et al., 2001 , and carbon dioxide radiometry Cutler et al., 1989 . In addition to the methods summarized in Table 2 , other techniques have been investigated but have received only modest development. These include electrochemical methods Patchett et al., 1989; Yang, 2008 , electronic particle counting Kubitschek, 1969 , microcalorimetry Forrest, 1972  monitored. Some methods may be highly developed with extensive equipment and information support, while others can still be considered to be at relatively early stages of research or currently developed for only a narrow application range. A few studies appear able to meet the challenges of pharmaceutical and medical device microbiology Zuluaga et al., 2009; Akselband et al., 2005; Dexter et al., 2003; Newby, 2000 . It is also important to remember that the term "rapid" is variously applied to techniques of 5 min to 24 h duration, the definition often reflecting the expectations of the user. However, a method that may be deemed rapid in application with a high bioburden may require an extended enrichment period in situations of lower or injured bioburden. Useful discussion and comparison of the principal methods can be found in the following works: general aspects Jarvis and Easter, 1987; Balows et al., 1989; Stannard et al., 1989; Blackburn, 1993; Watling and Leech, 1996; Stewart, 1997; Geis, 2006 , adenosine triphosphate ATP bioluminescence Jago et al., 1989; Stanley et al., 1989; Stewart et al., 1989; Stewart, 1990; Stewart, 1997; Dexter et al., 2003 , fluorescent 
Product Quality Assessment
The pharmaceutical and medical device industry has tended to be conservative in its approach to rapid methods for assessment of product quality. This is largely because of the regulatory constraints imposed upon these products. For this reason, much of the information accumulated in Table 4 is drawn from related industries, but using comparable products and environments. Table 4 clearly demonstrates the current low probability that any single method will satisfy the requirements for all types of pharmaceutical and medical device application, although some manufacturers are now seeking methods applicable to a collection of related products. It is unlikely that any rapid method can be immediately applied in a wide range of situations without first undertaking extensive protocol development. The sensitivity of all methods can be enhanced by sample enrichment but this will lead to an inevitable increase in analysis time; additionally, contaminants grow at different rates and this may result in a substantially different microbial flora from the original sampled product. In sterility testing, where the bioburden is quite likely to be low, rapid methods generally require sample enrichment or extended incubation period to reach the microbial levels required for detection, which significantly differs from rapid methods used in the food facilities. Food facilities have approved the use of rapid methods to detect microorganisms contaminating the food products, but pharmaceutical and medical device facilities have not officially approved rapid detection methods yet.
Process Hygiene
In general, the examination of in-process product samples can utilize the same methods of rapid analysis as that for raw materials and final products Table 4 . Surface hygiene assessment, using appropriate swabbing or surface sampling techniques, may require an enrichment period if low counts are expected; similarly, large volumes of water or air associated with the process may need to be sampled and concentrated by Beezer, 1980; Watling and Leech, 1996 , biophotometry Thomas et al., 1985 , and flow cytometry Akselband et al., 2005 . Practical details of these methods potentially applicable to the examination of microorganisms attached to medical devices bioburden can be found done in Denyer et al. 1993 . We recognize that many different types of bacteria, while remaining physiologically active, can enter periods of nonculturability: in this form they are termed viable but nonculturable VBNC Colwell, 1987; Kell et al., 1998; McDougald et al., 1998 . This may be an adaptive response to inimical environments; there is an evidence that this characteristic may be the dominant form in some environmental niches Bloomfield et al., 1998 . VBNC microorganisms are theoretically capable of product spoilage and may be a potential infectious threat Colwell et al., 1996; Rahman et al., 1996 . It is perhaps reassuring therefore to discover that direct fluorescent staining labeling techniques offer a suitable approach to the detection of VBNC microorganisms Kawai et al., 1999 . The ChemScan R process laser scanning cytometry routinely shows water bioburdens in excess of those determined by conventional culture, indicative of an otherwise undisclosed VBNC population e.g., Wallner et al., 1997 . 
USE OF RAPID METHODS IN PHAR-MACEUTICAL AND MEDICAL DEVICES
From a pharmaceutical and medical device perspective, the principal areas in which rapid methods may find application are given in Table 3 . A method may be required to provide quantitative or qualitative evidence of microbial presence survival of bioburden , some mechanism of contamination tracking, or to offer rapid confirmation of the absence of microorganisms. Few methods show complete promise in their range and relevance of reported applications Watling and Leech 1996 , Anonymous 1996 , 2 Bopp and Wachsmith 1981 , Anderson et al. 1986 , 3 Wassall et al. 1997 , 4 Senior et al. 1989 , 5 Bussey and Tsuji 1986 , 6 Blackburn et al. 1989 , Anonymous 2001 , 7 Webster 1986 , Woolridge 1989 , Tanaka et al. 1997 , Newby 2000 , 8 Kahn and FirstenbergEden 1984 , Kaiserman et al. 1989 , 9 Connolly et al. 1983 , 10 Dal Maso 1998 , 11 Watling and Leech 1996 , 12 Wilkins et al. 1980 , 13 Palmgren et al. 1986 , 14 Denyer and Ward 1983 , Denyer and Lynn 1987 , 15 Ladd et al. 1985 , Bridgett et al. 1993 , 16 Connolly et al. 1993 , 17 Holah et al. 1988 , 18 Mittelman et al. 1983 , Newby 1991 , Kawai et al. 1999 , 19 Newby 2000 , 20 Anonymous 1995 , 21 Wallner et al. 1997 , Gapp et al. 1999 , Reynolds and Fricker 1999 , Newby 2000 , 22 Alvarez et al. 1994 , 23 Jordan 2000 , 24 Newby 2000 , 25 Atlas 1991 , Maiwald et al. 1994 with biological indicators is necessary, which is required in the sterilization validation and GMP. To ensure that every reasonable opportunity is given for the recovery of stressed and injured indicator spores, sometimes a longer incubation period, often in excess of two weeks, is required before assurance of sterilizer efficacy can be given; this provides little opportunity for early detection of partial sterilizer failure. A commercial detection system in which a spore enzyme, -glucosidase reflective of spore viability , converts a nonfluorescent substrate into a fluorescent product within an hour offers one solution. Other approaches examined include ATP bioluminescence to detect spores surviving suboptimal sterilization processes Webster et al., 1988 and in vivo bioluminescence as a reporter of recombinant spore viability Stewart et al., 1989 . 
CONCLUSION
There are several developed rapid microbiological methods now becoming available that may have useful applications in pharmaceutical and medical devices; of these, ATP bioluminescence, fluorescent labeling, electrical resistance, and nucleic acid probes appear among the most promising Table 5 . Inevitably, no single method will satisfy easily all requirements, and further development will be needed to adapt them to the specific demands of the pharmaceutical and medical device situation. In this context, it is encouraging to see the developments in ATP bioluminescence offering increased sensitivity adenylate kinase amplification Corbitt et al., 2000 , potential specificity phage lysins Stewart, 1997 , phage lysis Wu et al., 2001 , and internal calibration against excipient effects caged ATP Calvert et al., 2000 , while proposed developments using filtration to ensure a sufficient microbial bioburden before examination.
Preservative Efficacy
The official preservative efficacy test methods require challenge periods of up to 28 days and the introduction of rapid methods in this situation would confer no meaningful benefit. Where rapid methodology can have an important role to play is in the rapid examination of several candidate preservative systems and their possible permutations of concentration and combination for use in new or developing formulations. Kinetic data from D-value determinations or estimation of growth-inhibitory concentrations can quickly provide a useful indication of preservative or formulation incompatibilities and can be used to compare the relative merits of potential preservative systems. Rapid methods have been applied to preservative evaluation Denyer, 1990; Connolly et al., 1993; Connolly et al., 1994 . It is important to distinguish between those methods used primarily to explore bacteriostatic behavior and those able to examine bactericidal activity. In the latter instance, enrichment or extended incubation periods may be necessary to detect low numbers of survivors bioburden , thereby extending the overall detection time.
In a product challenge designed to explore the capacity of a preservative system to withstand repeated microbial insults or to study the ability of spoilage microorganisms to survive and grow, kinetic information is of less importance and the detection methods summarized in Table 4 are potentially applicable.
Sterilizer Testing
Sterilization protocols require regular microbiological validation; for some processes, continual efficacy monitoring fluorescently labeled antibodies may offer specificity to laser scanning cytometry Reynolds and Fricker, 1999 . It is particularly pleasing to see that in the reference of Wu et al. 2001 , two technologies-phage interaction and ATP bioluminescence-come together in one application. The revolution in applied DNA technologies, particularly driven by medical diagnostics, offers major promise in the future for miniaturized nucleic acid-based detection systems; the recognition of gene families associated with particular microbial characteristics Stewart, 1997 offers a route to the detection of specific deteriogens and pathogens.
In choosing to employ rapid methods, the microbiologist should examine their prospective performances against the specific requirements for that sector. Some methods may require expensive equipment and offer full automation, and others represent only a small investment. The regulatory view of these methods is changing and they still officially have not been approved in medical and pharmaceutical area, but it will still be up to the microbiologist to demonstrate that the method chosen is fit for the purpose intended.
